Week Ending July 18, 2022

Access to hep C treatment reducing morbidity and mortality among people who inject drugs
“A longitudinal cohort study of persons with a history of injection drug use has found that more people who inject drugs (PWID) are receiving Hepatitis C virus (HCV) treatment, which is associated with significant reductions in liver disease and mortality.”

Liver Disease and Death Rates Fall After Hepatitis C Treatment Barriers Are Dismantled
“As obstacles to hepatitis C treatment uptake were removed, rates of hepatitis-related liver disease in marginalized groups plummeted, according to a new study in Baltimore, Maryland published in Annals of Internal Medicine.”

High Residual Liver Cancer Risk in HCV-Cured Cirrhosis
“A new study confirms the very high risk of hepatocellular carcinoma (HCC) faced by patients with cirrhosis who have been cured of hepatitis C, a finding the researchers hope will encourage clinicians to communicate risk information to patients and encourage regular HCC screening.”

Alcohol-Related Cirrhosis Deaths See Steep Rise
“A study by researchers at Florida Atlantic University’s (FAU) Schmidt College of Medicine documented a more than threefold increase in deaths from alcohol-related cirrhosis, an advanced form of alcohol-related liver disease, in the United States since 1999.”

Liver disease, deaths fall with lowered barriers to hepatitis drugs
“Treating intravenous drug users with hepatitis drugs at the community level significantly drove down liver disease and deaths over more than a decade, researchers reported in the Annals of Internal Medicine.”

Newly Diagnosed With Hepatitis C? Here’s How to Stay Healthy
“When you’re diagnosed with any new illness, you have to learn how to manage treatment and keep yourself as healthy as possible. That’s definitely the case with hepatitis C, an infection of the liver caused by the hepatitis C virus (HCV).”

7 Sneaky Signs of Hepatitis C You Should Know About
“It’s probably safe to say that hepatitis C is not high on your radar these days—if it ever was. The disease has become less notable since a new treatment was approved for it by the Food and Drug Administration (FDA) in 2016.”

The number of Americans injecting drugs skyrockets to nearly 3.7 million people in 2018, study finds
“The opioid epidemic has led to a meteoric rise in injection drug use over the past decade, according to a study funded by the Centers for Disease Control and Prevention, which experts say may also have contributed to an increase in overdoses and infectious diseases.”

Roche launches dual antigen and antibody diagnostic test for hepatitis c
“The Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus status from a single human plasma or serum sample.”

Natural Killer Group 2D Receptor and B1a Cells Crosstalk in Post-Hepatitis C Virus Infection Hepatocellular Carcinoma and Cirrhosis
“Hepatitis C virus (HCV) infection is a serious health concern and the leading cause of liver disease worldwide. Although present medications are helpful, they are costly and have unfavorable side effects. Understanding how HCV interacts with host cells could lead to the discovery of new cellular targets for developing innovative treatments.”